Back to company

ENKAM PHARMACEUTICALS ApS: Financial statements 2016

CVR: 25812921

ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -271,767 and a net result of DKK -345,030 compared with DKK -488,005 the year before. Equity amounted to DKK -608,430.

Gross Profit
-271,767 kr.
Profit/Loss
-345,030 kr.
Equity
-608,430 kr.
Total Assets
146,140 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--272 t.-345 t.-608 t.0
2015--426 t.-488 t.-263 t.-
2014-4.7 mio.2.8 mio.-1.9 mio.-
2013--2.6 mio.-3.7 mio.-4.7 mio.-
2012--1.1 mio.-2.5 mio.-3.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ENKAM PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

ENKAM PHARMACEUTICALS ApS: The 2015 annual report is outJun 14, 2016

ENKAM PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK -425,840, and the net result was DKK -488,005.

About ENKAM PHARMACEUTICALS ApS

ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 0 employees. In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity amounted to DKK -1,179,474.

Other financial years